342 related articles for article (PubMed ID: 16740737)
41. Coadministration of the aromatase inhibitor formestane and an isopropanolic extract of black cohosh in a rat model of chemically induced mammary carcinoma.
Nisslein T; Freudenstein J
Planta Med; 2007 Apr; 73(4):318-22. PubMed ID: 17354167
[TBL] [Abstract][Full Text] [Related]
42. Fas ligand expression in TM4 Sertoli cells is enhanced by estradiol "in situ" production.
Catalano S; Rizza P; Gu G; Barone I; Giordano C; Marsico S; Casaburi I; Middea E; Lanzino M; Pellegrino M; Andò S
J Cell Physiol; 2007 May; 211(2):448-56. PubMed ID: 17167783
[TBL] [Abstract][Full Text] [Related]
43. Oral grape seed extract inhibits prostate tumor growth and progression in TRAMP mice.
Raina K; Singh RP; Agarwal R; Agarwal C
Cancer Res; 2007 Jun; 67(12):5976-82. PubMed ID: 17575168
[TBL] [Abstract][Full Text] [Related]
44. Trichostatin A down-regulates CYP19 transcript and protein levels in MCF-7 breast cancer cells.
Łuczak MW; Jagodziński PP
Biomed Pharmacother; 2009 May; 63(4):262-6. PubMed ID: 18602794
[TBL] [Abstract][Full Text] [Related]
45. Regulation of aromatase P450 expression by puerarin in endometrial cell line RL95-2.
Li YW; Cai ZL; Shen W; Yang SS; Yu CQ
Zhong Xi Yi Jie He Xue Bao; 2008 Oct; 6(10):1017-23. PubMed ID: 18847535
[TBL] [Abstract][Full Text] [Related]
46. Dietary administration of the licorice flavonoid isoliquiritigenin deters the growth of MCF-7 cells overexpressing aromatase.
Ye L; Gho WM; Chan FL; Chen S; Leung LK
Int J Cancer; 2009 Mar; 124(5):1028-36. PubMed ID: 19065667
[TBL] [Abstract][Full Text] [Related]
47. Role of androgens on MCF-7 breast cancer cell growth and on the inhibitory effect of letrozole.
Macedo LF; Guo Z; Tilghman SL; Sabnis GJ; Qiu Y; Brodie A
Cancer Res; 2006 Aug; 66(15):7775-82. PubMed ID: 16885381
[TBL] [Abstract][Full Text] [Related]
48. In vivo efficacy of STX213, a second-generation steroid sulfatase inhibitor, for hormone-dependent breast cancer therapy.
Foster PA; Newman SP; Chander SK; Stengel C; Jhalli R; Woo LL; Potter BV; Reed MJ; Purohit A
Clin Cancer Res; 2006 Sep; 12(18):5543-9. PubMed ID: 17000691
[TBL] [Abstract][Full Text] [Related]
49. Aromatase and the breast: regulation and clinical aspects.
Miller WR
Maturitas; 2006 Jul; 54(4):335-41. PubMed ID: 16730141
[TBL] [Abstract][Full Text] [Related]
50. Jun proteins modulate the ovary-specific promoter of aromatase gene in ovarian granulosa cells via a cAMP-responsive element.
Ghosh S; Wu Y; Li R; Hu Y
Oncogene; 2005 Mar; 24(13):2236-46. PubMed ID: 15688015
[TBL] [Abstract][Full Text] [Related]
51. Tumor suppressor BRCA1 inhibits a breast cancer-associated promoter of the aromatase gene (CYP19) in human adipose stromal cells.
Ghosh S; Lu Y; Katz A; Hu Y; Li R
Am J Physiol Endocrinol Metab; 2007 Jan; 292(1):E246-52. PubMed ID: 16940470
[TBL] [Abstract][Full Text] [Related]
52. Inhibition of aromatase activity and expression in MCF-7 cells by the chemopreventive retinoid N-(4-hydroxy-phenyl)-retinamide.
Ciolino HP; Wang TT; Sathyamoorthy N
Br J Cancer; 2000 Aug; 83(3):333-7. PubMed ID: 10917548
[TBL] [Abstract][Full Text] [Related]
53. [The efficacy of autocatalytic casapse-3 driven by human telomerase reverse transcriptase promoter on human ovarian carcinoma].
Song Y; Shen K; Yu JR
Zhonghua Yi Xue Za Zhi; 2007 Nov; 87(41):2919-24. PubMed ID: 18261307
[TBL] [Abstract][Full Text] [Related]
54. CpG dinucleotide methylation of the CYP19 I.3/II promoter modulates cAMP-stimulated aromatase activity.
Demura M; Bulun SE
Mol Cell Endocrinol; 2008 Feb; 283(1-2):127-32. PubMed ID: 18201819
[TBL] [Abstract][Full Text] [Related]
55. Steroid metabolism in breast cancer.
Foster PA
Minerva Endocrinol; 2008 Mar; 33(1):27-37. PubMed ID: 18277377
[TBL] [Abstract][Full Text] [Related]
56. Tumor-specific RNAi targeting eIF4E suppresses tumor growth, induces apoptosis and enhances cisplatin cytotoxicity in human breast carcinoma cells.
Dong K; Wang R; Wang X; Lin F; Shen JJ; Gao P; Zhang HZ
Breast Cancer Res Treat; 2009 Feb; 113(3):443-56. PubMed ID: 18327707
[TBL] [Abstract][Full Text] [Related]
57. Inhibitory effects of Gleditsia sinensis fruit extract on telomerase activity and oncogenic expression in human esophageal squamous cell carcinoma.
Tang WK; Chui CH; Fatima S; Kok SH; Pak KC; Ou TM; Hui KS; Wong MM; Wong J; Law S; Tsao SW; Lam KY; Beh PS; Srivastava G; Ho KP; Chan AS; Tang JC
Int J Mol Med; 2007 Jun; 19(6):953-60. PubMed ID: 17487429
[TBL] [Abstract][Full Text] [Related]
58. Regulation of aromatase expression by the nuclear receptor LRH-1 in adipose tissue.
Clyne CD; Kovacic A; Speed CJ; Zhou J; Pezzi V; Simpson ER
Mol Cell Endocrinol; 2004 Feb; 215(1-2):39-44. PubMed ID: 15026173
[TBL] [Abstract][Full Text] [Related]
59. Melatonin modulates aromatase activity in MCF-7 human breast cancer cells.
Cos S; Martínez-Campa C; Mediavilla MD; Sánchez-Barceló EJ
J Pineal Res; 2005 Mar; 38(2):136-42. PubMed ID: 15683469
[TBL] [Abstract][Full Text] [Related]
60. Breast tumor aromatase: functional role and transcriptional regulation.
Chen S; Zhou D; Okubo T; Kao YC; Yang C
Endocr Relat Cancer; 1999 Jun; 6(2):149-56. PubMed ID: 10731103
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
